Research

2022 Research Grant Call

Research into improvements of the cancer pathway for childhood and young adult cancers

Project Details

£2.5 million research grant call supporting projects that improve the cancer pathway and quality of life for children and young adults with cancer. Funding is available for projects up to 3 years.

Invitation for preliminary proposal
30/09/2022

Deadline for preliminary proposal
14/11/2022 5:00 pm

Invitations for full proposals
09/01/2023

Deadline for full proposals
06/03/2023 5:00 pm

Overview

N.B. This funding round is now closed.

This is a £2.5 million Grant Call for research into improvements of the cancer pathway for childhood and young adult cancers. We are seeking proposals that focus on key questions in any area of cancer research which primarily addresses the needs of children and young adults with cancer and into improved quality of ongoing life.

The grant call went live on Friday 30 September 2022.

Apply

Submitted proposals must align with the strategic objectives outlined in the research strategy.

What can the funding be used for?

Our project grants are intended to provide funds for the employment of suitably qualified staff and the purchase of essential equipment and consumables for projects lasting up to 3 years that address the objectives outlined above. Please note that we will not contribute towards the cost of tenured posts, nor can we contribute towards institutional overheads. The maximum amount that can be applied for is up to £350,000 for applications from a single institution, or more for collaborations involving more than one institution, though most grants will be for less than this.

Who may apply?

Proposals must be submitted by a UK academic institution (university, hospital or research institute). We will consider funding international collaborations where researchers from a UK institution play a leading role. If a grant is awarded to such a collaboration, the UK institution must take overall responsibility for management of the project and must undertake to administer the funding. Please note that we will accept no more than two proposals from a single research group.

Application process and timetable

First stage application

The first stage is a preliminary proposal which must be submitted using our online grants portal, following the link below. Preliminary proposals are reviewed by our Scientific Advisory Panel who decide which proposals to put through to the second stage.

Decisions are based on the perceived NEED of the proposed research, the potential IMPACT of the proposed research and the capacity of the research team to deliver the proposed research.

Second stage application

Second stage applications will be subject to full, external peer review to assess the scientific quality of the detailed research proposal.

Timetable

The anticipated timeline is as follows but please note that these dates may be subject to change:

Invitation for preliminary proposal: by Friday 30 September 2022
Deadline for preliminary proposal: 5pm, Monday 14 November 2022
Invitations for full proposals: by Monday 9 January 2023
Deadline for full proposals: 5pm, Monday 6 March 2023
Awards finalised: May 2023

Registering

You can download full cost guidelines and read the full tender document relating to this call. If you have any questions relating to this grant call, please contact the Research team via email:

[email protected] More information on how to register via Flexi-Grant.

To register under this grant call, please apply here:

Apply

Contact

If you have any questions relating to this grant call,

Please contact the Research team via email:

[email protected]

Identifying new treatments for children with rhabdomyosarcoma

Related research – Dr Zoë Walters

Every year in the UK around 55 children are diagnosed with rhabdomyosarcoma, a cancer that affects connective tissues such

Accelerating the delivery of personalised treatment to children with neuroblastoma using MRI

Related research – Dr Yann Jamin

Using biomarkers has helped to improve response rates in adult cancers from 4-50%. We urgently need to get new treatments

Studying the role of ATRX in ALT positive cancers

Related research – Dr David Clynes

Cancers known as ALT positive include some incurable brain tumours that affect children. Our research project aims to uncover more